Skip to main content
OpenTrials
Completed

NCT Number: NCT03078244

Protocol for a Multicentre Survey of Patients With Treatment Resistant Hypertension

Project aims to determine the number of individuals with treatment resistant hypertension and to define the characteristics of these patients and estimate disease frequency. The study will be a retrospective review of medical record data based upon de-identified information and will require no patient contact.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Treatment Resistant Hypertension

Age range

18 year and older

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • > = 18 years of age
  • No known secondary cause of hypertension
  • History of uncontrolled hypertension while using 3 or more anti-hypertensive agents
  • Controlled blood pressure using 4 or more different anti-hypertensive agents

Exclusion criteria

N/A

Treatment and study plan

N/A, observational study

Other

Primary outcomes

  1. Number of adult subjects with treatment resistant hypertension

    Time frame: one year

Sponsors and collaborators

Lead sponsor

Emerald Clinical Inc.

Industry

Collaborators

  • Actelion
  • The George Institute

Registry information

Acronym: SPIRIT

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Mar 13, 2017
Registry last updated
Feb 19, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.